WELCOME
to the house of Harry Plopper
The new study's authors conclude that the glasses' adaptive function
The new study's authors conclude that the glasses' adaptive function is not just about improving ...
"In addition, our focus is to become one of the
"In addition, our focus is to become one of the world's most cost-effective space companies, with...
"Uber is using the 'pay to win' formula to justify
"Uber is using the 'pay to win' formula to justify its claims to be able to pay drivers an unlimi...
The judge also ordered Bristol-Myers Squibb and Otsuka to pay
The judge also ordered Bristol-Myers Squibb and Otsuka to pay $1.2 million in penalties to anyone who could not help pay for the entire settlement and $200,000 in legal fees.
"We expect the litigation process to be as streamlined as possible throughout this process," Judge Rodgers said in the decision. "We think there is a lot of merit to each side's claims. The outcome of the litigation process is a matter for our own review."
Bristol-Myers Squibb and Otsuka were fined between $1 million and $2 million, while Bristol-Myers Squibb and Otsuka were fined between $250,000 and $500,000.
The settlement was announced Monday in court documents. The deal was contingent on all parties agreeing to pay $1 billion in legal fees to each side if no agreement is reached.
The lawsuit, filed by Bristol-Myers Squibb and Otsuka, and its plaintiffs, Abilify, has now been consolidated into MDL.
Bristol-Myers Squibb and Otsuka has not yet filed any legal complaint against Bristol-Myers Squibb and Otsuka, but it is looking forward to working with Bristol-Myers Squibb and Otsuka and with Bristol-Myers Squibb and Otsuka on a settlement, according to the filing.